Eton Pharmaceuticals (ETON) Receivables - Net (2019 - 2025)
Eton Pharmaceuticals (ETON) has disclosed Receivables - Net for 7 consecutive years, with $11.8 million as the latest value for Q4 2025.
- Quarterly Receivables - Net rose 119.31% to $11.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.8 million through Dec 2025, up 119.31% year-over-year, with the annual reading at $11.8 million for FY2025, 119.31% up from the prior year.
- Receivables - Net hit $11.8 million in Q4 2025 for Eton Pharmaceuticals, down from $13.1 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $13.1 million in Q3 2025 to a low of $300000.0 in Q1 2021.
- Historically, Receivables - Net has averaged $3.9 million across 5 years, with a median of $3.5 million in 2023.
- Biggest five-year swings in Receivables - Net: skyrocketed 10316.67% in 2021 and later plummeted 62.96% in 2022.
- Year by year, Receivables - Net stood at $5.0 million in 2021, then crashed by 62.96% to $1.9 million in 2022, then skyrocketed by 84.18% to $3.4 million in 2023, then soared by 57.17% to $5.4 million in 2024, then surged by 119.31% to $11.8 million in 2025.
- Business Quant data shows Receivables - Net for ETON at $11.8 million in Q4 2025, $13.1 million in Q3 2025, and $5.0 million in Q2 2025.